Home
Conditions
Immunoproliferative Disorders

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

9,977 public trials 2,028 recruiting studies

Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Recruiting

Human BCMA Targeted T Cells Injection（BCMA CAR-T）for Subjects With R/R MM

NCT05594797

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
Locations: Shanghai Changzheng Hospital Shanghai, Shanghai Municipality, China

The First Affiliated Hospital of Wenzhou Medical University Wenzhou, Zhejiang, China

View Trial Details

Recruiting

Clinical Study of Senl-T7 CAR T Cells in the Treatment of Relapsed and Refractory CD7+ Acute T-ALL/T-LBL

NCT05626400

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
Locations: Hebei yanda Hospital Beijingcun, Hebei, China

View Trial Details

Recruiting

CD7 CAR-T Cells in T-cell Lymphoma/Leukemia

NCT05620680

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +6 more
Locations: Li Yu Shenzhen, Guangdong, China

View Trial Details

Recruiting

Efficacy and Safety of Lenalidomide Plus CHOP vs CHOP in Patients With Untreated Peripheral T-Cell Lymphoma

NCT04922567

Conditions: CHOP, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
Locations: 2nd Affiliated Hospital, School of Medicine, Zhejiang University Hangzhou, Zhejiang, China

View Trial Details

Recruiting

Allogeneic Hematopoietic Cell Transplantation From HLA-matched Donor After Flu-Mel-PTCy Versus Flu-Mel-ATG Reduced-intensity Conditioning

NCT03852407

Conditions: Acute Lymphoid Leukemia in Remission, Acute Myeloid Leukemia in Remission, Blood Protein Disorders, +33 more
Locations: ZNA Stuivenberg Antwerp, Belgium

AZ Sint Jan Brugge Bruges, Belgium

IJ Bordet Brussels, Belgium

UZ Brussel Brussels, Belgium

View Trial Details

Recruiting

PUMCH Dementia Longitudinal Cohort Study

NCT05023564

Conditions: Alzheimer Disease, Arterial Occlusive Diseases, Arteriosclerosis, +36 more
Locations: Peking Union Medical College Hospital Beijing, China

View Trial Details

Recruiting

A Study to Investigate the Safety and Tolerability of SCR-6920 Capsule in Patients With Advanced Malignant Tumors

NCT05528055

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: Shandong Cancer Hospital Jinan, Shandong, China

View Trial Details

Recruiting

B-cell Mature Non-Hodgkin's Lymphoma Treatment Protocol in Children and Adolescents 2021

NCT05518383

Conditions: Burkitt Lymphoma, DNA Virus Infections, Diffuse Large B-cell Lymphoma, +19 more
Locations: Dmitry Rogachev National Medical Research Center Of Pediatric Hematology, Oncology and Immunology Moscow, RF, Russia

View Trial Details

Recruiting

Prephase Treatment With Prednisone +/- Vitamin D Supplementation Followed by Immunochemotherapy

NCT04442412

Conditions: Diffuse Large B-cell Lymphoma, Elderly Patients, Hemic and Lymphatic Diseases, +10 more
Locations: SC Ematologia Spedali Civili Brescia, BS, Italy

UO Ematologia e CTMO di Piacenza Piacenza, PC, Italy

Ospedale Oncologico regionale CROB Rionero in Vulture, Piacenza, Italy

A.O. SS. Antonio e Biagio e Cesare Arrigo - S.C. Ematologia Alessandria, Italy

View all 49 locations

View Trial Details

Recruiting

Allogeneic Stem Cell Transplantation in Relapsed/Refractory T-, NK/T-cell Lymphomas

NCT02859402

Conditions: Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
Locations: Dong-A University Busan, South Korea

Keimyung University Dongsan Medical Center Daegu, South Korea

View Trial Details

Immunoproliferative Disorders

Immunoproliferative Disorders trial results

Related conditions